7 Insertion of article 5B in the principal Order
After article 5A of the principal Order, insert the following article—

“5B Exemption for products consisting of or containing pseudoephedrine salts or ephedrine base or salts
1 A medicinal product falling within article 3(h) shall be exempt from the restrictions imposed by section 58(2) (restrictions on sale, supply and administration) if the conditions in paragraph (2) are satisfied—
2 The conditions referred to in this paragraph are that—
(a) the medicinal product sold or supplied to a person must not be sold or supplied at the same time as another medicinal product that consists of or contains—
(i) in the case of pseudoephedrine salts, ephedrine base or salts;
(ii) in the case of ephedrine base or salts, pseudoephedrine salts; and
(b) the medicinal product or products sold or supplied to a person at any one time must not in total contain more than—
(i) in the case of pseudoephedrine salts, 720mg pseudoephedrine salts;
(ii) in the case of ephedrine base or salts, 180mg ephedrine base or salts.”

.